Summary
- More than 300 anti-obesity drugs are currently being developed worldwide
- Market for weight-loss medications could be worth between £64bn and £120bn by 2030
- Potential for these medications to treat a range of conditions beyond just weight loss
- Fierce competition among pharmaceutical companies to grab market share
